Individual and synergistic cytokine effects controlling the expansion of cord blood CD34+ cells and megakaryocyte progenitors in culture

Cytotherapy

Volumn 13, Issue 4, 2011, Pages 467-480

  Pineault, Nicolas ^a,b   Cortin, Valérie ^a   Boyer, Lucie ^a   Garnier, Alain ^b   Robert, Amélie ^a   Thérien, Cynthia ^c   Roy, Denis Claude ^c,d  

^a R and D Department   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cord blood; cytokines; ex vivo expansion; megakaryocytes; platelet recovery

Indexed keywords

CYTOKINE; FLT3 LIGAND; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 9; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; CD34+ CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; STEM CELL; UMBILICAL CORD BLOOD;

EID: 79952692887     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.530651     Document Type: Article

References (53)

1. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol. 2007;137:20-35. (Pubitemid 46426403)
2. Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, et al. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion. 2006;46:1934-42. (Pubitemid 44631601)
3. Prince HM, Simmons PJ, Whitty G, Wall DP, Barber L, Toner GC, et al. Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol. 2004;126:536-45. (Pubitemid 39093096)
4. Decaudin D, Vantelon JM, Bourhis JH, Farace F, Bonnet ML, Guillier M, et al. Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma. Bone Marrow Transplant. 2004;34: 1089-93. (Pubitemid 40028843)
5. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilicalcord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276-85. (Pubitemid 39552743)
6. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101:5061-7. (Pubitemid 36857774)
7. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368-76.
8. Datta NS, Williams JL, Caldwell J, Curry AM, Ashcraft EK, Long MW Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell. 1996;7:209-23. (Pubitemid 26064367)
9. Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 1997;89: 2679-88. (Pubitemid 27172552)
10. Williams JL, Pipia GG, Datta NS, Long MW. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 1998;91:4118-26. (Pubitemid 28261973)
11. Van den Oudenrijn S, von dem Borne AE, de Haas M. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 2000;28:1054-61.
12. Shaw PH, Gilligan D, Wang XM, Thall PF, Corey SJ. Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biol Blood Marrow Transplant. 2003;9:151-6.
13. +CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med. 1996;183:2551-8. (Pubitemid 26192365)
14. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA. 1997; 94:4698-703.
15. Audet J, Miller CL, Eaves CJ, Piret JM. Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotechnol Bioeng. 2002;80:393-404. (Pubitemid 35230933)
16. Fujiki H, Kimura T, Mnamiguchi H, Harada S, Wang J, Nakao M, et al. Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol. 2002;30:1373-80. (Pubitemid 35449793)
17. Baksh D, Davies JE, Zandstra PW. Soluble factor crosstalk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood. 2005;106:3012-9. (Pubitemid 41565893)
18. Cortin V, Garnier A, Pineault N, Lemieux R, Boyer L, Proulx C. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol. 2005;33:1182-91. (Pubitemid 41416966)
19. Wang W, Horner DN, Chen WL, Zandstra PW, Audet J. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects. Biotechnol Bioeng. 2008;99:1261-72. (Pubitemid 351462782)
20. Chen TW, Hwang SM, Chu IM, Hsu SC, Hsieh TB, Yao CL. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure. Exp Hematol. 2009;37: 1330-39.
21. Lotem J, Sachs L. Cytokine controlof developmental programs in normal hematopoiesis and leukemia. Oncogene. 2002;21:3284-94. (Pubitemid 34587704)
22. + cells using a short twophase culture system. J Immunol Methods. 2008;332:82-91.
23. +-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res. 2003;12:179-88. (Pubitemid 36529569)
24. Proulx C, Dupuis N, St-Amour I, Boyer L, Lemieux R. Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. Biotechnol Bioeng. 2004;88:675-80. (Pubitemid 40775323)
25. Pineault N, Boucher J-F, Cayer M-P, Palmqvist L, Boyer L, Lemieux R, et al. Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev. 2008;17:483-94.
26. Box GEP, Hunter WG, Hunter JS. In: Box GEP, Hunter WG, Hunter JS. Statistics for Experimenters: An Introduction to Design, Data Analysis and Model Building. New York: John Wiley & Sons; 1978.
27. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood. 1994;84:4045-52.
28. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369:533-8.
29. Schipper LF, Brand A, Reniers NC, Melief CJ, Willemze R, Fibbe WE. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol. 1998;101:425-35. (Pubitemid 28266933)
30. Dolzhanskiy A, Basch RS, Karpatkin S. The development of human megakaryocytes. III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. Blood. 1997;89: 426-34. (Pubitemid 27051677)
31. Schattner M, Lefebvre P, Mingolelli SS, Goolsby CL, Rademaker A, White JG, et al. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells. 1996;14:207-14. (Pubitemid 26109202)
32. De Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev. 2005;14:415-24. (Pubitemid 41243705)
33. Feng Y, Zhang L, Xiao ZJ, Li B, Liu B, Fan CG, et al. An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol. 2005;33: 1537-43. (Pubitemid 41773854)
34. + cells. Stem Cells. 2006; 24:2877-87. (Pubitemid 46053024)
35. Sigurjonsson OE, Gudmundsson KO, Haraldsdottir V, Rafnar T, Agnarsson BA, Gudmundsson S. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development. Stem Cells Dev. 2004;13: 183-91. (Pubitemid 38590921)
36. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, et al. Expansion of human NOD/SCID-repop-ulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000; 105:1013-21. (Pubitemid 30203074)
37. Rollini P, Kaiser S, Faes-van't Hull E, Kapp U, Leyvraz S. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood. 2004;103:1166-70. (Pubitemid 38129587)
38. Kollet O, Aviram R, Chebath J, Ben-Hur H, Nagler A, Shultz L, et al. The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice. Blood. 1999;94: 923-31. (Pubitemid 29361823)
39. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997; 90:1345-64. (Pubitemid 27355406)
40. Papayannopoulou T, Brice M, Farrer D, Kaushansky K. Insights into the cellular mechanisms of erythropoietin -thrombopoietin synergy. Exp Hematol. 1996;24:660-9. (Pubitemid 26145055)
41. Salles, II, Thijs T, Brunaud C, De Meyer SF, Thys J, Vanhoorelbeke K, et al. Human platelets produced in non-obese diabetic/severe combined immunodeficient (NOD/ SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow modelof thrombosis. Blood. 2009;114:5044-51.
42. Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005;202:1599-611. (Pubitemid 41746605)
43. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood. 2000;96:4185-93.
44. +Lin-cells with preserved ability to engraft SCID-hu bone. Blood. 1998; 91:1206-15. (Pubitemid 28086873)
45. Ramsfjell V, Bryder D, Bjorgvinsdottir H, Kornfalt S, Nilsson L, Borge OJ, et al. Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells. Blood. 1999;94:4093-102.
46. + cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol. 2008;36:244-52.
47. + cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol. 2006;34:943-50.
48. Tijssen MR, van Hennik PB, di Summa F, Zwaginga JJ, van der Schoot CE, Voermans C. Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice. Leukemia. 2008;22: 203-8.
49. + cells. Stem Cells. 2004;22:135-43. (Pubitemid 38282629)
50. Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol. 2003;31:413-20. (Pubitemid 36579367)
51. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood. 1965;26:720-31.
52. Stenberg PE, Levin J. Mechanisms of platelet production. Blood Cells. 1989;15:23-47. (Pubitemid 19034966)
53. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16:232-6.